Literature DB >> 8456948

c-fos oncogene underexpression in salivary gland tumors as measured by in situ hybridization.

C Birek1, E Lui, I Dardick.   

Abstract

Tissue from 35 salivary gland tumors and 14 normal salivary glands was analyzed by in situ hybridization and computer-assisted morphometry for the expression of the c-fos oncogene. The normal salivary gland tissues were found to express c-fos focally, mainly in the acinar secretory cells. The majority of the cells in the normal tissues showed a high level of expression (47.74 +/- 5.31% of cells had 46 to 60 grains per cell and another 45.79 +/- 2.18% showed > 60 grains per cell). All the tumors examined exhibited a relatively low, uniform distribution of c-fos expression. For example, in the poorly differentiated adenocarcinomas, 96.83 +/- 04% of the cells were found to have < 15 grains per cell. A general linear model for multivariate analysis showed a significant difference between the various tumor types and the normal salivary gland tissues (P = 0.0001). These data support the hypothesis that salivary gland tumors belong to a group of epithelial neoplasias in which the loss of cellular differentiation is linked with underexpression of the c-fos oncogene.

Entities:  

Mesh:

Year:  1993        PMID: 8456948      PMCID: PMC1886811     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  38 in total

Review 1.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

2.  Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain.

Authors:  P Sassone-Corsi; L J Ransone; W W Lamph; I M Verma
Journal:  Nature       Date:  1988-12-15       Impact factor: 49.962

3.  Expression of c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study.

Authors:  N M Kernohan; K Blessing; G King; I P Corbett; I D Miller
Journal:  J Pathol       Date:  1991-01       Impact factor: 7.996

4.  Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein.

Authors:  F van Straaten; R Müller; T Curran; C Van Beveren; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

5.  Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

Authors:  R Lupu; R Colomer; G Zugmaier; J Sarup; M Shepard; D Slamon; M E Lippman
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

6.  FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA.

Authors:  T Curran; G Peters; C Van Beveren; N M Teich; I M Verma
Journal:  J Virol       Date:  1982-11       Impact factor: 5.103

7.  Detection of fos protein during osteogenesis by monoclonal antibodies.

Authors:  P De Togni; H Niman; V Raymond; P Sawchenko; I M Verma
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

8.  Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes.

Authors:  R Müller; E F Wagner
Journal:  Nature       Date:  1984 Oct 4-10       Impact factor: 49.962

9.  Glucocorticoid-induced growth inhibition with enhanced expression of ductal epithelium of human salivary gland adenocarcinoma cells transplanted into athymic nude mice.

Authors:  S Hatakeyama; M Sashima; K Shirasuna; M Satoh; A Suzuki
Journal:  Cancer       Date:  1988-08-15       Impact factor: 6.860

10.  Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma.

Authors:  S P Naber; Y Tsutsumi; S Yin; S A Zolnay; H Mobtaker; P J Marks; S J McKenzie; R A DeLellis; H J Wolfe
Journal:  Am J Clin Pathol       Date:  1990-08       Impact factor: 2.493

View more
  1 in total

1.  Perturbation of BRD4 protein function by BRD4-NUT protein abrogates cellular differentiation in NUT midline carcinoma.

Authors:  Junpeng Yan; Jason Diaz; Jing Jiao; Ranran Wang; Jianxin You
Journal:  J Biol Chem       Date:  2011-06-07       Impact factor: 5.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.